Patents by Inventor Annette Merdes

Annette Merdes has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • USE OF 4-BENZAMIDE IN THE TREATMENT OF NEUROPATHIC PAIN
    Publication number: 20160051513
    Abstract: Use of 4-{3-[cis-hexahydrocyclopenta[c]pyrrol-2(1H)-yl]propoxy}benzamide of formula (I): or an addition salt thereof with a pharmaceutically acceptable acid or base, in the treatment of neuropathic pain and of cognitive disorders, depression and anxiety associated with that pain.
    Type: Application
    Filed: March 21, 2014
    Publication date: February 25, 2016
    Inventors: Aurore SORS, Annette MERDES
  • COMBINATION OF 4- BENZAMIDE AND A NMDA RECEPTOR ANTAGONIST AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
    Publication number: 20150080448
    Abstract: Combination between 4-{3-[cis-hexahydrocyclopenta[c]pyrrol-2(1H)-yl]propoxy}-benzamide of formula (I): or an addition salt thereof with a pharmaceutically acceptable acid or base, and an NMDA glutamatergic receptor antagonist. Medicinal products containing the same which are useful in the treatment of cognitive disturbances associated with cerebral ageing and neurodegenerative diseases.
    Type: Application
    Filed: November 25, 2014
    Publication date: March 19, 2015
    Inventors: Aurore SORS, Caryn Trocme-Thibierge, Annette Merdes
  • Combination of 4-{3-[-hexahydrocyclopenta[]pyrrol-2(1)-yl]propoxy}benzamide and a NMDA receptor antagonist and pharmaceutical compositions containing the same
    Patent number: 8921409
    Abstract: Combination between 4-{3-[cis-hexahydrocyclopenta[c]pyrrol-2(1H)-yl]propoxy}-benzamide of formula (I): or an addition salt thereof with a pharmaceutically acceptable acid or base, and an NMDA glutamatergic receptor antagonist. Medicinal products containing the same which are useful in the treatment of cognitive disturbances associated with cerebral ageing and neurodegenerative diseases.
    Type: Grant
    Filed: December 6, 2012
    Date of Patent: December 30, 2014
    Assignee: Les Laboratoires Servier
    Inventors: Aurore Sors, Caryn Trocme-Thibierge, Annette Merdes